US Patent Issued to Pharmosa Biopharm on Sept. 29 for "Pharmaceutical composition for controlled release of weak acid drugs and uses thereof" (Taiwanese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,200, issued on Sept. 29, was assigned to Pharmosa Biopharm Inc. (Taipei City, Taiwan).

"Pharmaceutical composition for controlled release of weak acid drugs and uses thereof" was invented by Pei Kan (Taipei City, Taiwan), Yi Fong Lin (New Taipei City, Taiwan) and Ko Chieh Chen (Taipei City, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are pharmaceutical compositions containing at least one liposome, said liposome comprise an external lipid bilayer including at least one vesicle-forming phospholipid and less than 15 mole % of sterol; and an internal aqueous medium including a weak acid drug and weak acid salt. The pharmaceut...